Pituitary stalk interruption syndrome. A rare congenital anatomical defect of the pituitary gland characterized by a very thin or “interrupted” pituitary stalk; an ectopic or absent posterior pituitary; and aplasia or hypoplasia anterior pituitary, with permanent deficit of growth hormone (GH).
« Back to Glossary IndexNews
Related News

Jul 15th, 2024
The Fanconi Cancer Foundation (FCF) is excited to announce that Dr. Isis Sroka has been named CEO effective August 1, 2024. She succeeds Mark Quinlan who served as Executive Director since 2017 and recently announced his departure. Quinlan will continue in an advisory role with FCF through a transition period.

Nov 7th, 2024
Institution: Laboratorio de Citogenetica, Instituto Nacional de Pediatría, Mexico City, México Area of expertise: Medical genetics, dysmorphology. My work: I am a medical geneticist from Mexico City, introduced to the field of Fanconi anemia (FA) by my mentor, Dr. Sara Frias, whom...

Feb 25th, 2025
This virtual meeting is an opportunity for individuals diagnosed with Fanconi Anemia Neurological Syndrome (FANS) and their families to gather, find mutual support for navigating FANS, and hear from leading FANS physician and researcher, Dr. Stella Davies. Dr. Davies is...